Episode Details

Welcome back to another episode of The BioHub, we were delighted to welcome on Abid Ansari, Chief Financial Officer at General Oncology, a clinical-stage biopharma company focused on first-in-class therapies for metastatic cancer. With more than two decades of experience in the biotechnology and life sciences sectors, Abid has built his reputation as a strategic finance executive who bridges capital, innovation, and growth. Over his career, he’s led major capital raises — including a $153 million Series C at Artios and a $146 million IPO at Precision BioSciences — and driven business development deals, licensing agreements, and M&A transactions. Earlier in his journey, Abid held roles at GSK in deal finance and portfolio management, contributing to high-stakes transactions such as the acquisition of Bristol Myers Squibb’s HIV portfolio and licensing agreements with Adaptimmune